
AVAH Stock Forecast & Price Target
AVAH Analyst Ratings
Bulls say
Aveanna Healthcare Holdings Inc. demonstrated robust financial performance, highlighted by a 27.3% year-over-year revenue growth in its Home Health & Hospice segment, reaching $69.3 million, with gross margins slightly exceeding targeted ranges. The Medical Solutions segment also reported a significant 21.3% revenue increase to $52.5 million, coupled with a gross margin expansion of 570 basis points to 50.0%, benefiting from improved cash collections. Furthermore, the Private Duty Services segment achieved an impressive 28.1% revenue growth year-over-year, driven by successful volume and rate increases, with strong performance further supported by the integration of the Thrive acquisition.
Bears say
Aveanna Healthcare Holdings Inc. is facing fundamental challenges that suggest a negative outlook for the stock. The reported decline in the Private Duty Nursing (PDN) spread rate from $12.60 to $12.12 indicates ongoing wage pressures that could erode profitability. Additionally, the company is dealing with significant headwinds, including reimbursement pressures, high leverage, and increasing competition, which are projected to contribute to a 10% downside to adjusted EBITDA estimates for fiscal years 2026 and 2027.
This aggregate rating is based on analysts' research of Aveanna Healthcare Holdings and is not a guaranteed prediction by Public.com or investment advice.
AVAH Analyst Forecast & Price Prediction
Start investing in AVAH
Order type
Buy in
Order amount
Est. shares
0 shares